{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T23:53:17Z","timestamp":1770508397158,"version":"3.49.0"},"reference-count":106,"publisher":"Informa UK Limited","issue":"sup1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Neuroscience"],"published-print":{"date-parts":[[2011,2,28]]},"DOI":"10.3109\/00207454.2010.539306","type":"journal-article","created":{"date-parts":[[2011,1,19]],"date-time":"2011-01-19T06:30:55Z","timestamp":1295418655000},"page":"22-34","source":"Crossref","is-referenced-by-count":13,"title":["New Trends in the Science of Botulinum Toxin-A as Applied in Dystonia"],"prefix":"10.3109","volume":"121","author":[{"given":"Andy","family":"Pickett","sequence":"first","affiliation":[{"name":"1Biologicals Science and Technology Ipsen Biopharm Limited, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond L.","family":"Rosales","sequence":"additional","affiliation":[{"name":"2Department of Neurology, Neurosciences and Psychiatry, The University of Santo Tomas, MetroManila, Philippines"},{"name":"3Neurophysiology and Movement Disorders, St. Luke's Medical Center and Metropolitan Medical Center-CNS, MetroManila, Philippines"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2011,1,19]]},"reference":[{"key":"e_1_3_1_2_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03033927"},{"key":"e_1_3_1_3_1","doi-asserted-by":"crossref","unstructured":"Alpiner N. (2009). Botulinum toxin injections using computerised tomography guidance for enhanced anatomical localization. Presented at 70th Annual Assembly of the American Academy of Physical Medicine and Rehabilitation 22\u201326 October 2009 Austin TX USA Poster 303.","DOI":"10.1016\/j.pmrj.2009.08.327"},{"key":"e_1_3_1_4_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.1999.tb00032.x"},{"issue":"2","key":"e_1_3_1_5_1","first-page":"A521","article-title":"Botox\u00ae (botulinum toxin type A) purified neurotoxin complex prepared from the new bulk toxin retains the same preclinical efficacy as the original but with reduced immunogenicity","volume":"52","author":"Aoki R.","year":"1999","unstructured":"Aoki, R., Merlino, G., Spanoyannis, A., & Wheeler, L. (1999). Botox\u00ae (botulinum toxin type A) purified neurotoxin complex prepared from the new bulk toxin retains the same preclinical efficacy as the original but with reduced immunogenicity. Neurology, 52(Suppl 2), A521\u2013A522.","journal-title":"Neurology"},{"key":"e_1_3_1_6_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.8.1059"},{"key":"e_1_3_1_7_1","doi-asserted-by":"publisher","DOI":"10.1099\/mic.0.28862-0"},{"key":"e_1_3_1_8_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.1185"},{"key":"e_1_3_1_9_1","doi-asserted-by":"publisher","DOI":"10.1212\/01.WNL.0000163767.99354.C3"},{"key":"e_1_3_1_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s12640-009-9023-3"},{"key":"e_1_3_1_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2008.02507.x"},{"issue":"1","key":"e_1_3_1_12_1","first-page":"276","article-title":"Transcranial magnetic stimulation in movement disorders","volume":"51","author":"Berardelli A.","year":"1999","unstructured":"Berardelli, A. (1999). Transcranial magnetic stimulation in movement disorders. Electroencephalography Clinical Neurophysiology, 51(Suppl.1), 276\u2013280.","journal-title":"Electroencephalography Clinical Neurophysiology"},{"key":"e_1_3_1_13_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/108.3.593"},{"key":"e_1_3_1_14_1","doi-asserted-by":"publisher","DOI":"10.1097\/00002341-199103000-00007"},{"key":"e_1_3_1_15_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.46.1.26"},{"key":"e_1_3_1_16_1","doi-asserted-by":"publisher","DOI":"10.3233\/NRE-2008-23301"},{"key":"e_1_3_1_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/BF03033928"},{"key":"e_1_3_1_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molimm.2006.03.011"},{"key":"e_1_3_1_19_1","doi-asserted-by":"publisher","DOI":"10.1091\/mbc.e08-07-0765"},{"key":"e_1_3_1_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20022"},{"key":"e_1_3_1_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2009.02877.x"},{"key":"e_1_3_1_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199601)19:1<10::AID-MUS2>3.0.CO;2-B"},{"key":"e_1_3_1_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2008.04.030"},{"key":"e_1_3_1_24_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/121.5.801"},{"key":"e_1_3_1_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2009.02879.x"},{"issue":"2","key":"e_1_3_1_26_1","first-page":"R20","article-title":"In vitro stability of botulinum toxin complex preparations at physiological pH and temperature","volume":"365","author":"Friday D.","year":"2002","unstructured":"Friday, D., Bigalke, H., & Frevert, J. (2002). In vitro stability of botulinum toxin complex preparations at physiological pH and temperature. Naunyn-Schmiedebergs Archives of Pharmacology, 365(Suppl 2), R20.","journal-title":"Naunyn-Schmiedebergs Archives of Pharmacology"},{"key":"e_1_3_1_27_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1022590514771"},{"key":"e_1_3_1_28_1","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/974943"},{"key":"e_1_3_1_29_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410290407"},{"key":"e_1_3_1_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(97)00151-2"},{"key":"e_1_3_1_31_1","unstructured":"Goodmurphy C. W. (1996). A comparative morphological study of two human facial muscles: The orbicularis oculi and the corrugator supercilii. Masters thesis University of British Columbia August 1996."},{"key":"e_1_3_1_32_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1098-2353(1999)12:1<1::AID-CA1>3.0.CO;2-J"},{"key":"e_1_3_1_33_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/120.12.2179"},{"key":"e_1_3_1_34_1","first-page":"1537","article-title":"Preliminary crystallographic studies of a protease-resistant botulinum neurotoxin associated protein Hn-33","volume":"55","author":"Hadfield A. T.","year":"1999","unstructured":"Hadfield, A. T., Petsko, G., Lindo, P., & Singh, B. R. (1999). Preliminary crystallographic studies of a protease-resistant botulinum neurotoxin associated protein Hn-33. Acta Crystallographica, D55, 1537\u20131539.","journal-title":"Acta Crystallographica"},{"key":"e_1_3_1_35_1","volume-title":"Clinical Uses of BotulinumToxins","author":"Hambleton P.","year":"2007","unstructured":"Hambleton, P., Pickett, A. M., & Shone, C. C. (2007). Botulinum toxin: From menace to medicine. In A. B. Ward & M. P. Barnes (eds.), Clinical Uses of BotulinumToxins., Cambridge, Cambridge University Press."},{"key":"e_1_3_1_36_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0185(199710)249:2<276::AID-AR15>3.0.CO;2-L"},{"key":"e_1_3_1_37_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e3181692735"},{"key":"e_1_3_1_38_1","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.1449"},{"key":"e_1_3_1_39_1","doi-asserted-by":"publisher","DOI":"10.1002\/mus.1186"},{"key":"e_1_3_1_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/0924-980X(95)93310-P"},{"key":"e_1_3_1_41_1","doi-asserted-by":"publisher","DOI":"10.2165\/00003495-200767050-00003"},{"key":"e_1_3_1_42_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410380206"},{"key":"e_1_3_1_43_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870120412"},{"key":"e_1_3_1_44_1","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(199907)14:4<642::AID-MDS1014>3.0.CO;2-M"},{"key":"e_1_3_1_45_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1473-2165.2008.00395.x"},{"key":"e_1_3_1_46_1","doi-asserted-by":"publisher","DOI":"10.1080\/00207450600674525"},{"key":"e_1_3_1_47_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2009.01.017"},{"key":"e_1_3_1_48_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.130.3378.763"},{"key":"e_1_3_1_49_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e3181914d0a"},{"issue":"6","key":"e_1_3_1_50_1","doi-asserted-by":"crossref","first-page":"S66\u2013S71","DOI":"10.1016\/j.asj.2009.09.009","article-title":"An evaluation of neutralizing antibody induction during treatment of glabellar lines with a new US formulation of botulinum neurotoxin type A","volume":"29","author":"Lawrence I.","year":"2009","unstructured":"Lawrence, I., & Moy, R. (2009). An evaluation of neutralizing antibody induction during treatment of glabellar lines with a new US formulation of botulinum neurotoxin type A. Aesthetic Surgery Journal, 29(Suppl 6S), S66\u2013S71.","journal-title":"Aesthetic Surgery Journal"},{"key":"e_1_3_1_51_1","first-page":"301","article-title":"Production of anti-neurotoxin antibody is enhanced by two subcomponents, HA1 and HA3b, of Clostridium botulinum type B 16S toxin-haemagglutinin","volume":"113","author":"Lee J. C.","year":"2005","unstructured":"Lee, J. C., Yokata, K., Arimitsu, H., Hwang, H-J., Sakaguchi, Y., Cui, J., (2005). Production of anti-neurotoxin antibody is enhanced by two subcomponents, HA1 and HA3b, of Clostridium botulinum type B 16S toxin-haemagglutinin. Microbiology, 113, 301\u2013312.","journal-title":"Microbiology"},{"key":"e_1_3_1_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1353-8020(02)00042-1"},{"key":"e_1_3_1_53_1","first-page":"1","article-title":"Botulinum toxin-A injections via electrical motor point stimulation to treat writer's cramp: Pilot study","volume":"4","author":"Lim E. C. H.","year":"2006","unstructured":"Lim, E. C. H., Quek, A. M. L., & Seet, R. C. S. (2006). Botulinum toxin-A injections via electrical motor point stimulation to treat writer's cramp: Pilot study. Neurology, Neurophysiology, and Neuroscience, 4, 1\u20137.","journal-title":"Neurology, Neurophysiology, and Neuroscience"},{"key":"e_1_3_1_54_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-008-0175-8"},{"key":"e_1_3_1_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mri.2009.12.023"},{"key":"e_1_3_1_56_1","doi-asserted-by":"publisher","DOI":"10.1097\/WNF.0b013e3181acef9b"},{"key":"e_1_3_1_57_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0301-0082(96)00042-1"},{"key":"e_1_3_1_58_1","doi-asserted-by":"publisher","DOI":"10.1179\/174313209X405137"},{"key":"e_1_3_1_59_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.58.5.805"},{"key":"e_1_3_1_60_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/123.9.1813"},{"key":"e_1_3_1_61_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/112.3.681"},{"key":"e_1_3_1_62_1","unstructured":"National Institutes of Health (NIH) Consensus Development Program. (1990). Clinical Use of Botulinum Toxin. NIH Consensus Development Conference Statement November 12\u201314 1990. Accessed as http:\/\/consensus.nih.gov\/1990\/1990BotulinumToxin083html.htm 20 April 2010."},{"key":"e_1_3_1_63_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079904125003962"},{"key":"e_1_3_1_64_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/120.3.409"},{"issue":"1","key":"e_1_3_1_65_1","first-page":"We-156","article-title":"A meta-analysis of neutralizing antibody conversion following a specific formulation of botulinum toxin type A (BoNTA, Allergan, Inc.)","volume":"24","author":"Naumann M.","year":"2009","unstructured":"Naumann, M., Abu-Shakra, S., Boodhoo, T., Miller-Messana, M. A., Demos, G., & Brin, M. F. (2009). A meta-analysis of neutralizing antibody conversion following a specific formulation of botulinum toxin type A (BoNTA, Allergan, Inc.). Movement Disorders, 24(Suppl 1), We-156.","journal-title":"Movement Disorders"},{"key":"e_1_3_1_66_1","doi-asserted-by":"publisher","DOI":"10.1007\/PL00007848"},{"key":"e_1_3_1_67_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.40.5.824"},{"key":"e_1_3_1_68_1","doi-asserted-by":"publisher","DOI":"10.1504\/TBJ.2008.018956"},{"key":"e_1_3_1_69_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-510X(00)00439-1"},{"key":"e_1_3_1_70_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.toxicon.2009.03.020"},{"key":"e_1_3_1_71_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2710.2008.00904.x"},{"issue":"9","key":"e_1_3_1_72_1","first-page":"1085","article-title":"Formulation composition of botulinum toxins in clinical use","volume":"9","author":"Pickett A.","year":"2010","unstructured":"Pickett, A., & Perrow, K. (2010). Formulation composition of botulinum toxins in clinical use. Journal of Drugs in Dermatology, 9(9), 1085\u20131091.","journal-title":"Journal of Drugs in Dermatology"},{"key":"e_1_3_1_73_1","doi-asserted-by":"publisher","DOI":"10.1080\/14764170802094282"},{"key":"e_1_3_1_74_1","doi-asserted-by":"publisher","DOI":"10.1504\/TBJ.2008.018951"},{"key":"e_1_3_1_75_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/118.3.801"},{"key":"e_1_3_1_76_1","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awp213"},{"issue":"6","key":"e_1_3_1_77_1","first-page":"337","article-title":"Efficacy and safety of a new bulk toxin of botulinum toxin in cervical dystonia: A blinded evaluation","volume":"22","author":"Racette B. A.","year":"1999","unstructured":"Racette, B. A., McGee-Minnich, L., & Perlmutter, J. S. (1999). Efficacy and safety of a new bulk toxin of botulinum toxin in cervical dystonia: A blinded evaluation. Clinical Neuropharmacology, 22(6), 337\u2013339.","journal-title":"Clinical Neuropharmacology"},{"key":"e_1_3_1_78_1","doi-asserted-by":"publisher","DOI":"10.1089\/fpd.2006.0076"},{"key":"e_1_3_1_79_1","doi-asserted-by":"publisher","DOI":"10.1016\/0168-5597(92)90005-V"},{"key":"e_1_3_1_80_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.59.5.493"},{"key":"e_1_3_1_81_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-005-0323-3"},{"key":"e_1_3_1_82_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.870130123"},{"key":"e_1_3_1_83_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00702-007-0869-3"},{"key":"e_1_3_1_84_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2010.03056.x"},{"key":"e_1_3_1_85_1","doi-asserted-by":"publisher","DOI":"10.1016\/0924-980X(95)93315-K"},{"key":"e_1_3_1_86_1","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4598(199604)19:4<488::AID-MUS9>3.0.CO;2-8"},{"key":"e_1_3_1_87_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2006.01438.x"},{"key":"e_1_3_1_88_1","unstructured":"Rosales R. L. Delgado M. S. & Rosales M. E. (2002). Spasticity X-linked dystonia parkinsonism and botulinum toxin A: The local scenario. Proceedings of the 3rd World Congress of Neurological Rehabilitation Battistin Dam Tonin (eds) Monduzzi Editore pp. 121\u2013126."},{"issue":"9","key":"e_1_3_1_89_1","first-page":"S103","article-title":"Botulinum toxin A and muscle afferent block in X-linked dystonia-parkinsonism of Panay","volume":"19","author":"Rosales R. L.","year":"2004","unstructured":"Rosales, R. L., Delgado, M., & Malicdan, M. (2004). Botulinum toxin A and muscle afferent block in X-linked dystonia-parkinsonism of Panay. Movement Disorders, 19(Suppl 9), S103\u2013S104.","journal-title":"Movement Disorders"},{"key":"e_1_3_1_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/0163-7258(82)90061-4"},{"key":"e_1_3_1_91_1","first-page":"28","article-title":"Botulinum toxin treatment of strabismus","volume":"35","author":"Scott A.","year":"1985","unstructured":"Scott, A. (1985). Botulinum toxin treatment of strabismus. American Orthodontics Journal, 35, 28\u201329.","journal-title":"American Orthodontics Journal"},{"key":"e_1_3_1_92_1","first-page":"734","article-title":"Botulinum toxin injection of the eye muscles to correct strabismus","volume":"79","author":"Scott A. B.","year":"1981","unstructured":"Scott, A. B. (1981). Botulinum toxin injection of the eye muscles to correct strabismus. Transactions of the American Opthalmological Society, 79, 734\u2013770.","journal-title":"Transactions of the American Opthalmological Society"},{"key":"e_1_3_1_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0733-8635(03)00019-6"},{"key":"e_1_3_1_94_1","first-page":"924","article-title":"Pharmacologic weakening of extraocular muscles","volume":"12","author":"Scott A. B.","year":"1973","unstructured":"Scott, A. B., Rosenbaum, A., & Collins, C. C. (1973). Pharmacologic weakening of extraocular muscles. Investigative Ophthalmology, 12, 924\u2013927.","journal-title":"Investigative Ophthalmology"},{"key":"e_1_3_1_95_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1552-6569.2009.00375.x"},{"key":"e_1_3_1_96_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0001271"},{"key":"e_1_3_1_97_1","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20270"},{"key":"e_1_3_1_98_1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1093\/cercor\/bhh017","article-title":"Impaired modulation of intracortical inhibition in focal hand dystonia","volume":"14","author":"Stinear C. M.","year":"2004","unstructured":"Stinear, C. M., & Byblow, W. D. (2004). Impaired modulation of intracortical inhibition in focal hand dystonia. Cerebral Cortex, 14 555\u2013561.","journal-title":"Cerebral Cortex"},{"key":"e_1_3_1_99_1","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.200910119"},{"key":"e_1_3_1_100_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.107.044024"},{"key":"e_1_3_1_101_1","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(199905)14:3<473::AID-MDS1014>3.0.CO;2-L"},{"key":"e_1_3_1_102_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.20801"},{"key":"e_1_3_1_103_1","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp.54.4.310"},{"key":"e_1_3_1_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-9861(53)80014-7"},{"key":"e_1_3_1_105_1","doi-asserted-by":"publisher","DOI":"10.1002\/mds.21759"},{"key":"e_1_3_1_106_1","doi-asserted-by":"publisher","DOI":"10.1017\/CBO9780511544842"},{"key":"e_1_3_1_107_1","doi-asserted-by":"publisher","DOI":"10.1093\/ajhp\/61.suppl_6.S5"}],"container-title":["International Journal of Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/00207454.2010.539306","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T23:08:14Z","timestamp":1770419294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/00207454.2010.539306"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,19]]},"references-count":106,"journal-issue":{"issue":"sup1","published-print":{"date-parts":[[2011,2,28]]}},"alternative-id":["10.3109\/00207454.2010.539306"],"URL":"https:\/\/doi.org\/10.3109\/00207454.2010.539306","relation":{},"ISSN":["0020-7454","1543-5245"],"issn-type":[{"value":"0020-7454","type":"print"},{"value":"1543-5245","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,19]]}}}